NCT01754181

Brief Summary

The main objective is to assess if the Diabeloop algorithm provides better glycemic control than a "manual" usual algorithm of patients with type 1 diabetes treated by insulin pump during meals, and during activity qualified "moderate" to "severe" by the patients. The study will be conducted in 18 patients. The investigation centers are: CHSF (for Diabeloop algorithm test during activity), CHU of Grenoble and CHU of Toulouse (for Diabeloop algorithm test during meals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Mar 2013

Shorter than P25 for phase_3

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 21, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

October 27, 2014

Status Verified

October 1, 2014

Enrollment Period

3 months

First QC Date

December 18, 2012

Last Update Submit

October 24, 2014

Conditions

Keywords

Glycemic control algorithmclosed loopartificial pancreas

Outcome Measures

Primary Outcomes (1)

  • Time spent in glucose reference intervals

    After the end of the tests

Secondary Outcomes (1)

  • Measuring glucose sensor 2h, 3h and 4h post-prandial and AUC, in every situation tested to evaluate the efficacy and safety (time spent in hypoglycemia)

    After the end of the tests

Other Outcomes (1)

  • Comparison of glucose sensor 2h, 3h and 4h post-prandial and AUC in conditions identical meals for each trigger level (50 or 75%). Measuring AUC during and 2 hours after physical activity, then to lunch time, during dinner and throughout the night.

    After the end of the tests

Study Arms (2)

Proposed treatment by Diabeloop algorithm

EXPERIMENTAL

the insulin dose is calculated by the algorithm based on the usual treatment of the patient, the ratio I / C, the intensity of physical activity and blood glucose sensor.

Drug: Insulin

usual treatment

NO INTERVENTION

Interventions

the intervention is applied only at the dose of insulin

Proposed treatment by Diabeloop algorithm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with type 1 diabetes treated by external insulin pump;
  • Patients with HbA1c \<8.5%.
  • Patients aged 18 years or less;
  • Patient who signed consent;
  • Patient affiliated with Social Security.
  • For Grenoble and Toulouse Centers (Prandial algorithm test : MEAL):
  • Patient is practicing functional insulin therapy is a fixed meal plan.
  • For CHSF center (test of algorithm during activity):
  • Patient able to perform moderate or intense activity during 30 minutes.

You may not qualify if:

  • Patients with type 2 diabetes
  • All serious diseases that could interfere with the study
  • Insulin resistance and obesity (BMI\> 30 kg/m2 and / or insulin requirements\> 2 U / kg / day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centre Hospitalier Sud Francilien

Évry, 91058, France

Location

University Hospital of Grenoble

Grenoble, 38043, France

Location

University Hospital of Toulouse

Toulouse, 31403, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Insulin

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Officials

  • Sylvia FRANC, MD

    Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

    PRINCIPAL INVESTIGATOR
  • Pierre-Yves BENHAMOU, Pr.

    CHU of Grenoble

    PRINCIPAL INVESTIGATOR
  • Guillaume CHARPENTIER, MD

    Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2012

First Posted

December 21, 2012

Study Start

March 1, 2013

Primary Completion

June 1, 2013

Study Completion

July 1, 2013

Last Updated

October 27, 2014

Record last verified: 2014-10

Locations